Offer - Urjas Oil for just ₹ 1 X
Syndopa CR 125 Tablet (10) is a prescription medicine that is available as a Tablet. The alternative uses of Syndopa CR 125 Tablet (10) have also been explained below.
The correct dosage of Syndopa CR 125 Tablet (10) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Syndopa CR 125 Tablet (10) include Nausea or vomiting, Headache, Infection. Apart from the aforementioned side effects, Syndopa CR 125 Tablet (10) can also lead to other problems, which have been listed below. These side effects of Syndopa CR 125 Tablet (10) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Syndopa CR 125 Tablet (10) has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Syndopa CR 125 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Syndopa CR 125 Tablet (10) related warnings section.
Syndopa CR 125 Tablet (10) is contraindicated in people with pre-existing medical conditions like Arrhythmia, Low Blood Pressure (Hypotension), Depression as it can result in adverse effects. The section on Syndopa CR 125 Tablet (10) contraindications lists all such conditions.
Drug interactions for Syndopa CR 125 Tablet (10) have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Syndopa CR 125 Tablet (10) is not safe while driving, and is is not addictive in nature.
Syndopa CR 125 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Syndopa CR 125 Tablet (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Syndopa. It is best to stop taking Syndopa immediately and inform your doctor if you notice any discomfort.
Is the use of Syndopa CR 125 Tablet (10) safe during breastfeeding?
Side effects of Syndopa for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Syndopa CR 125 Tablet (10) on the Kidneys?
Syndopa rarely affects the kidneys.
What is the effect of Syndopa CR 125 Tablet (10) on the Liver?
Syndopa is rarely harmful for the liver.
What is the effect of Syndopa CR 125 Tablet (10) on the Heart?
Syndopa may have mild side effects on the heart. Most people will never see any effect on the heart.
Syndopa CR 125 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Syndopa CR 125 Tablet (10) unless your doctor advises you to do so -
Is this Syndopa CR 125 Tablet (10) habit forming or addictive?
Yes, you can get addicted to Syndopa CR 125 Tablet (10). It is essential that you take [medicine] only after doctor's recommendation.
Interaction between Food and Syndopa CR 125 Tablet (10)
Taking Syndopa CR 125 Tablet (10) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Syndopa CR 125 Tablet (10)
Taking alcohol with Syndopa CR 125 Tablet (10) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 426-429
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 54-55
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 279-281
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 429-430
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lodosyn® (carbidopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sinemet® (carbidopa-levodopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rytary® (carbidopa-levodopa)